Trends in the prevalence of metabolic syndrome among Jordanian adults following COVID-19
Therapeutic Advances in Endocrinology and Metabolism · 2026-03 · 17
DOI: 10.1177/20420188261431012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Endocrinology and Metabolism, online erschienen am 19.03.2026. Verfasst von Islam Al-Shami und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition and Dietetics, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa, Jordan. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Several negative outcomes have been documented post-COVID-19 pandemic, including many cardiometabolic abnormalities associated with metabolic syndrome (MetS).
Objectives
The study aims to evaluate the prevalence of MetS among Jordanian adults post-COVID-19 and compare these results with previous findings.
Design
A cross-sectional study.
Methods
A total of 5188 adults of both sexes (age >18 years) were recruited. Body weight, height, waist circumference (WC), fasting plasma glucose, high-density lipoprotein cholesterol (HDL-C), triglycerides, and blood pressure were measured.
Results
The crude prevalence of MetS, using both the International Diabetes Federation (IDF) and the Adult Treatment Panel III (ATP III) diagnostic criteria, was 42.9% (32.5% in males and 46.9% in females). There was no change in the crude prevalence of MetS among the total population between 2017 (48.2% and 44.1%) and 2024 (48.1% and 45.0%) by IDF and ATP III criteria, respectively ( p > 0.05). In comparison, the age-standardized prevalences were 44.6% (95% CI 43.3%–45.9%) for ATP III and 47.7% (95% CI 46.4%–49.0%) for IDF. The main contributing factors for MetS, according to ATP III, were low HDL-C (65.4%) and enlarged WC (60.4%). However, according to IDF criteria, enlarged WC (76.9%) was followed by low HDL-C (65.4%).
Conclusion
Although the crude prevalence of MetS stayed relatively stable before and after COVID-19, age-standardized data show a noticeable upward trend, pointing to an increasing cardiometabolic burden. These findings highlight the urgent need for wide-ranging, population-level strategies that emphasize lifestyle modifications, screening, and early intervention to address metabolic risks.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Nutrition and Dietetics, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa, Jordan.
- Department of Nutrition and Food Science, Faculty of Allied Medical Sciences, Zarqa University College, Al-Balqa Applied University, Zarqa, Jordan.
ORCID-Profile: Buthaina Alkhatib
Zitieren
APA
Al-Shami, I., Alkhatib, B., Agraib, L., & Shawabkeh, A. T. (2026). Trends in the prevalence of metabolic syndrome among Jordanian adults following COVID-19. Therapeutic Advances in Endocrinology and Metabolism, 17. https://doi.org/10.1177/20420188261431012
Vancouver
Al-Shami I, Alkhatib B, Agraib L, Shawabkeh AT. Trends in the prevalence of metabolic syndrome among Jordanian adults following COVID-19. Therapeutic Advances in Endocrinology and Metabolism. 2026;17. doi:10.1177/20420188261431012
BibTeX
@article{AlShami2026,
author = {Al-Shami, Islam and Alkhatib, Buthaina and Agraib, Lana and Shawabkeh, Asem Taher},
title = {Trends in the prevalence of metabolic syndrome among Jordanian adults following COVID-19},
journal = {Therapeutic Advances in Endocrinology and Metabolism},
year = {2026},
volume = {17},
doi = {10.1177/20420188261431012}
}
EUVIMED